Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  HCP, Inc.    HCP

Delayed Quote. Delayed  - 05/27 10:01:03 pm
33.04 USD   +1.10%
05/28 HCP SHAREHOLDER : Kahn Swick & Foti, LLC Reminds Investors with Loss..
05/28 IMPORTANT SHARE : Lundin Law PC Announces Securities Class Action La..
05/25 Khang & Khang LLP Announces an Investigation of Claims Against HC..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Sales2 1002 266-2 5382 5892 592
Operating income (EBITDA)1 7081 343-7681 7561 6961 743
Operating profit (EBIT)1 296883-5881 1311 1961 010
Pre-Tax Profit (EBT)852-----
Net income969920-561677695797
P/E ratio17,122,0-31,623,720,526,6
EPS ( $ )2,132,00-1,211,401,611,24
Dividend per Share ( $ )2,102,182,262,272,272,42
Yield5,78%4,95%5,91%6,88%6,86%7,33%
Reference price ( $ )36.3244.0338.2433.0433.0433.04
Announcement Date02/11/2014
01:00pm
02/10/2015
01:00pm
----
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Debt---9 9699 6819 152
Finance------
Operating income (EBITDA)1 7081 343-7681 7561 6961 743
Leverage
(Debt/EBITDA)
---5,68x5,71x5,25x
Capital Expenditure195503-65,666,0-
Book Value Per Share (BVPS)23,5 $23,4 $20,1 $19,4 $18,9 $17,8 $
Cash Flow per Share2,52 $2,69 $2,64 $2,68 $2,63 $2,85 $
Announcement Date02/11/2014
01:00pm
02/10/2015
01:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 15 433 M$ -
Entreprise Value (EV) 25 401 M$ 25 114 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 23,7x 20,5x
Capitalization / Revenue 6,08x 5,96x
EV / Revenue 10,0x 9,70x
EV / EBITDA 14,5x 14,8x
Yield (DPS / Price) 6,88% 6,86%
Price to book (Price / BVPS) 1,70x 1,75x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 44,6% 46,2%
operating Leverage (Delta EBIT / Delta Sales) - 2,83x
Net Margin (Net Profit / Revenue) 26,7% 26,8%
ROA (Net Profit / Asset) 3,65% 4,10%
ROE (Net Profit / Equities) 8,75% 8,89%
Rate of Dividend 163% 141%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   2,59% 2,55%
Cash Flow / Sales 49,3% 47,4%
Capital Intensity (Assets / Sales) 7,31x 6,55x
Financial Leverage (Net Debt / EBITDA) 5,68x 5,71x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend